CoChat
Sign Up
Cited by 130

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Dextran Formulations as Effective Delivery Systems of Therapeutic Agents

Petrovici, Anca Roxana, Pinteala, Mariana, Simionescu, Natalia·2023·Molecules
DOI 10.3390/molecules28031086PMC PMC9920038
Open this paper in CoChat — free account

Abstract

Dextran is by far one of the most interesting non-toxic, bio-compatible macromolecules, an exopolysaccharide biosynthesized by lactic acid bacteria. It has been extensively used as a major component in many types of drug-delivery systems (DDS), which can be submitted to the next in-vivo testing stages, and may be proposed for clinical trials or pharmaceutical use approval. An important aspect to consider in order to maintain high DDS’ biocompatibility is the use of dextran obtained by fermentation processes and with a minimum chemical modification degree. By performing chemical modifications, artefacts can appear in the dextran spatial structure that can lead to decreased biocompatibility or even cytotoxicity. The present review aims to systematize DDS depending on the dextran type used and the biologically active compounds transported, in order to obtain desired therapeutic effects. So far, pure dextran and modified dextran such as acetalated, oxidised, carboxymethyl, diethylaminoethyl-dextran and dextran sulphate sodium, were used to develop several DDSs: microspheres, microparticles, nanoparticles, nanodroplets, liposomes, micelles and nanomicelles, hydrogels, films, nanowires, bio-conjugates, medical adhesives and others. The DDS are critically presented by structures, biocompatibility, drugs loaded and therapeutic points of view in order to highlight future therapeutic perspectives.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules28031086

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 135

  1. Cortesi, 1999, Dextran cross-linked gelatin microspheres as a drug delivery system, Eur. J. Pharm. Biopharm., 47, 153, 10.1016/S0939-6411(98)00076-9 · DOI
  2. Constantin, 2014, Do cyclodextrins bound to dextran microspheres act as sustained delivery systems of drugs?, Int. J. Pharm., 469, 1, 10.1016/j.ijpharm.2014.04.016 · DOI
  3. Xie, 2022, Acetalated dextran microparticles for the smart delivery of pyraclostrobin to control Sclerotinia diseases, Carbohydr. Polym., 291, 119576, 10.1016/j.carbpol.2022.119576 · DOI
  4. Kauffman, 2012, Optimization of rapamycin-loaded acetalated dextran microparticles for immunosuppression, Int. J. Pharm., 422, 356, 10.1016/j.ijpharm.2011.10.034 · DOI
  5. Huang, 2019, Preparation and drug delivery of dextran-drug complex, Drug Deliv., 26, 252, 10.1080/10717544.2019.1580322 · DOI
  6. Zamani, 2022, Synthesis and characterization of phase shift dextran stabilized nanodroplets for ultrasound-induced cancer therapy: A novel nanobiotechnology approach, J. Biotechnol., 350, 17, 10.1016/j.jbiotec.2022.04.003 · DOI
  7. Mufamadi, 2011, A Review on Composite Liposomal Technologies for Specialized Drug Delivery, J. Drug Deliv., 2011, 939851, 10.1155/2011/939851 · DOI
  8. Malekhosseini, 2020, Fabrication and characterization of hydrocortisone loaded Dextran-Poly Lactic-co-Glycolic acid micelle, Heliyon, 6, e03975, 10.1016/j.heliyon.2020.e03975 · DOI
  9. Shaki, 2018, Self-assembled amphiphilic-dextran nanomicelles for delivery of rapamycin, J. Drug Deliv. Sci. Technol., 44, 333, 10.1016/j.jddst.2018.01.010 · DOI
  10. Qu, 2019, Biocompatible conductive hydrogels based on dextran and aniline trimer as electro-responsive drug delivery system for localized drug release, Int. J. Biol. Macromol., 140, 255, 10.1016/j.ijbiomac.2019.08.120 · DOI
  11. Marchal, 2021, Rheological investigation of the influence of dextran on the self-assembly of lysine derivatives in water/dimethylsulfoxide mixtures, Colloids Surf. A Physicochem. Eng. Asp., 625, 126908, 10.1016/j.colsurfa.2021.126908 · DOI
  12. Zhou, 2022, A bioactive dextran-based hydrogel promote the healing of infected wounds via antibacterial and immunomodulatory, Carbohydr. Polym., 291, 119558, 10.1016/j.carbpol.2022.119558 · DOI
  13. Delvart, 2022, Dextran-based polyelectrolyte multilayers: Effect of charge density on film build-up and morphology, Colloids Surf. B Biointerfaces, 210, 112258, 10.1016/j.colsurfb.2021.112258 · DOI
  14. Lee, 2022, Enhanced deposition of Fe(III)-tannic acid complex nanofilm by Fe(III)-embedded dextran nanocoating, Appl. Surf. Sci., 573, 151598, 10.1016/j.apsusc.2021.151598 · DOI
  15. Raganato, 2022, Self-assembling nanowires from a linear l,d-peptide conjugated to the dextran end group, Int. J. Biol. Macromol., 207, 656, 10.1016/j.ijbiomac.2022.03.050 · DOI
  16. Joshy, 2018, Novel core-shell dextran hybrid nanosystem for anti-viral drug delivery, Mater. Sci. Eng. C, 93, 864, 10.1016/j.msec.2018.08.015 · DOI
  17. Hyon, 2022, Elucidating the degradation mechanism of a self-degradable dextran-based medical adhesive, Carbohydr. Polym., 278, 118949, 10.1016/j.carbpol.2021.118949 · DOI
  18. Moydeen, 2018, Fabrication of electrospun poly(vinyl alcohol)/dextran nanofibers via emulsion process as drug delivery system: Kinetics and in vitro release study, Int. J. Biol. Macromol., 116, 1250, 10.1016/j.ijbiomac.2018.05.130 · DOI
  19. Banerjee, 2021, Dextran-based scaffolds for in-situ hydrogelation: Use for next generation of bioartificial cardiac tissues, Carbohydr. Polym., 262, 117924, 10.1016/j.carbpol.2021.117924 · DOI · Paper page
  20. Pawlak, 2022, Multilayer dextran derivative based capsules fighting bacteria resistant to Antibiotic: Case of Kanamycin-Resistant Escherichia coli, Int. J. Biol. Macromol., 200, 242, 10.1016/j.ijbiomac.2021.12.123 · DOI
  21. Odeniyi, 2019, Starch nanoparticles in drug delivery: A review, Polym. Med., 48, 41, 10.17219/pim/99993 · DOI
  22. Rodrigues, 2012, Recent applications of starch derivatives in nanodrug delivery, Carbohydr. Polym., 87, 987, 10.1016/j.carbpol.2011.09.044 · DOI
  23. Zhong, H., Gao, X., Cheng, C., Liu, C., Wang, Q., and Han, X. (2020). The Structural Characteristics of Seaweed Polysaccharides and Their Application in Gel Drug Delivery Systems. Mar. Drugs, 18. · DOI
  24. Oprea, 2020, Recent advances in composites based on cellulose derivatives for biomedical applications, Carbohydr. Polym., 247, 116683, 10.1016/j.carbpol.2020.116683 · DOI
  25. Huo, 2020, Co-delivery of silybin and paclitaxel by dextran-based nanoparticles for effective anti-tumor treatment through chemotherapy sensitization and microenvironment modulation, J. Control. Release, 321, 198, 10.1016/j.jconrel.2020.02.017 · DOI
  26. Yue, 2019, Facile design and development of photoluminescent graphene quantum dots grafted dextran/glycol-polymeric hydrogel for thermoresponsive triggered delivery of buprenorphine on pain management in tissue implantation, J. Photochem. Photobiol. B Biol., 197, 111530, 10.1016/j.jphotobiol.2019.111530 · DOI
  27. Yilmaz, 2022, Characterisation and functional roles of a highly branched dextran produced by a bee pollen isolate Leuconostoc mesenteroides BI-20, Food Biosci., 45, 101330, 10.1016/j.fbio.2021.101330 · DOI
  28. Cassimiro, 2013, Preparation and characterisation of Dextran-70 hydrogel for controlled release of praziquantel, Brazilian J. Pharm. Sci., 49, 75, 10.1590/S1984-82502013000100009 · DOI
  29. Jamwal, 2019, New glucose oxidase-immobilized stimuli-responsive dextran nanoparticles for insulin delivery, Int. J. Biol. Macromol., 123, 968, 10.1016/j.ijbiomac.2018.11.147 · DOI
  30. Tiryaki, 2020, Novel organic/inorganic hybrid nanoparticles as enzyme-triggered drug delivery systems: Dextran and Dextran aldehyde coated silica aerogels, J. Drug Deliv. Sci. Technol., 56, 101517, 10.1016/j.jddst.2020.101517 · DOI
  31. Han, 2014, Dextran synthesized by Leuconostoc mesenteroides BD1710 in tomato juice supplemented with sucrose, Carbohydr. Polym., 112, 556, 10.1016/j.carbpol.2014.06.035 · DOI
  32. Wang, 2021, Challenges and opportunities for wheat alternative grains in breadmaking: Ex-situ- versus in-situ-produced dextran, Trends Food Sci. Technol., 113, 232, 10.1016/j.tifs.2021.05.003 · DOI
  33. Wang, 2015, Characterization of an exopolysaccharide produced by Lactobacillus plantarum YW11 isolated from Tibet Kefir, Carbohydr. Polym., 125, 16, 10.1016/j.carbpol.2015.03.003 · DOI
  34. Maingret, 2022, Pickering emulsions stabilized by biodegradable dextran-based nanoparticles featuring enzyme responsiveness and co-encapsulation of actives, Carbohydr. Polym., 284, 119146, 10.1016/j.carbpol.2022.119146 · DOI
  35. Kasaai, 2012, Dilute solution properties and degree of chain branching for dextran, Carbohydr. Polym., 88, 373, 10.1016/j.carbpol.2011.12.012 · DOI
  36. Padmanabhan, 2002, Production of insoluble dextran using cell-bound dextransucrase of Leuconostoc mesenteroides NRRL B-523, Carbohydr. Res., 337, 1529, 10.1016/S0008-6215(02)00214-8 · DOI
  37. Taboubi, 2021, Role of dextran in stabilization of polypyrrole nanoparticles for photoacoustic imaging, Eur. Polym. J., 157, 110634, 10.1016/j.eurpolymj.2021.110634 · DOI
  38. Hu, 2022, In-situ formable dextran/chitosan-based hydrogels functionalized with collagen and EGF for diabetic wounds healing, Biomater. Adv., 136, 212773, 10.1016/j.bioadv.2022.212773 · DOI
  39. Bakrania, 2017, Repeated dose 28-day oral toxicity study of DEAE-Dextran in mice: An advancement in safety chemotherapeutics, Regul. Toxicol. Pharmacol., 88, 262, 10.1016/j.yrtph.2017.07.005 · DOI
  40. Zhang, 2021, Polydopamine-incorporated dextran hydrogel drug carrier with tailorable structure for wound healing, Carbohydr. Polym., 253, 117213, 10.1016/j.carbpol.2020.117213 · DOI
  41. Chechushkov, 2016, Dextran loading protects macrophages from lipid peroxidation and induces a Keap1/Nrf2/ARE-dependent antioxidant response, Life Sci., 166, 100, 10.1016/j.lfs.2016.10.013 · DOI
  42. Nguyen, 2021, Data on the uptake of CpG-loaded amino-dextran nanoparticles by antigen-presenting cells, Data Br., 35, 106883, 10.1016/j.dib.2021.106883 · DOI
  43. Alibolandi, 2017, Fabrication of aptamer decorated dextran coated nano-graphene oxide for targeted drug delivery, Carbohydr. Polym., 155, 218, 10.1016/j.carbpol.2016.08.046 · DOI
  44. Park, 2016, The complete genome sequence of a lactic acid bacterium Leuconostoc mesenteroides ssp. dextranicum strain DSM 20484T, J. Biotechnol., 219, 3, 10.1016/j.jbiotec.2015.12.009 · DOI
  45. Du, 2022, Analysis of the structure and properties of dextran produced by Weissella confusa, Int. J. Biol. Macromol., 204, 677, 10.1016/j.ijbiomac.2022.02.038 · DOI
  46. Robyt, 1974, The mechanism of dextransucrase action. Direction of dextran biosynthesis, Arch. Biochem. Biophys., 165, 634, 10.1016/0003-9861(74)90291-4 · DOI
  47. Robyt, 2008, Dextransucrase and the mechanism for dextran biosynthesis, Carbohydr. Res., 343, 3039, 10.1016/j.carres.2008.09.012 · DOI
  48. 1993, Effect of pH and aeration on dextran production by Leuconostoc mesenteroides, Enzyme Microb. Technol., 15, 334, 10.1016/0141-0229(93)90160-4 · DOI
  49. Falconer, 2011, Biosynthesis of dextrans with different molecular weights by selecting the concentration of Leuconostoc mesenteroides B-512FMC dextransucrase, the sucrose concentration, and the temperature, Carbohydr. Res., 346, 280, 10.1016/j.carres.2010.10.024 · DOI
  50. Schmid, 2018, Recent insights in microbial exopolysaccharide biosynthesis and engineering strategies, Curr. Opin. Biotechnol., 53, 130, 10.1016/j.copbio.2018.01.005 · DOI
  51. Pintado, 2020, Efficiency of purification methods on the recovery of exopolysaccharides from fermentation media, Carbohydr. Polym., 231, 115703, 10.1016/j.carbpol.2019.115703 · DOI
  52. Wang, 2022, In situ production of vitamin B12 and dextran in soya flour and rice bran: A tool to improve flavour and texture of B12-fortified bread, LWT, 161, 113407, 10.1016/j.lwt.2022.113407 · DOI
  53. Petrovici, 2018, Biopolymer biosynthesis by lactic acid bacteria strain in four different culture media, Rev. Roum. Chim., 63, 637
  54. Dimofte, A., Simionescu, N., Petrovici, A.R., and Spiridon, I. (2022). Probiotic Properties of Weissella confusa PP29 on Hibiscus sabdariffa L. Media. Fermentation, 8. · DOI
  55. Petrovici, 2017, Effects of culture medium composition on biosynthesis of exopolysaccharides, Cellul. Chem. Technol., 51, 821
  56. Zhu, 2018, Purification, characterization and antioxidant activity of the exopolysaccharide from Weissella cibaria SJ14 isolated from Sichuan paocai, Int. J. Biol. Macromol., 115, 820, 10.1016/j.ijbiomac.2018.04.067 · DOI
  57. Du, 2018, Purification, characterization and antioxidant activity of dextran produced by Leuconostoc pseudomesenteroides from homemade wine, Carbohydr. Polym., 198, 529, 10.1016/j.carbpol.2018.06.116 · DOI
  58. Yilmaz, 2022, Structural and bioactive characteristics of a dextran produced by Lactobacillus kunkeei AK1, Int. J. Biol. Macromol., 200, 293, 10.1016/j.ijbiomac.2022.01.012 · DOI
  59. Li, 2022, Structural characterization of exopolysaccharides from Weissella cibaria NC516.11 in distiller grains and its improvement in gluten-free dough, Int. J. Biol. Macromol., 199, 17, 10.1016/j.ijbiomac.2021.12.089 · DOI
  60. Chen, 2022, Super-resolution imaging reveals the subcellular distribution of dextran at the nanoscale in living cells, Chin. Chem. Lett., 33, 1865, 10.1016/j.cclet.2021.10.025 · DOI
  61. Kannaujiya, 2022, Co-encapsulation of l-asparaginase and etoposide in dextran nanoparticles for synergistic effect in chronic myeloid leukemia cells, Int. J. Pharm., 622, 121796, 10.1016/j.ijpharm.2022.121796 · DOI
  62. Li, 2013, Boronate-dextran: An acid-responsive biodegradable polymer for drug delivery, Biomaterials, 34, 8504, 10.1016/j.biomaterials.2013.07.053 · DOI
  63. Bachelder, 2017, Acetalated Dextran: A Tunable and Acid-Labile Biopolymer with Facile Synthesis and a Range of Applications, Chem. Rev., 117, 1915, 10.1021/acs.chemrev.6b00532 · DOI
  64. Kauffman, 2012, Synthesis and characterization of acetalated dextran polymer and microparticles with ethanol as a degradation product, ACS Appl. Mater. Interfaces, 4, 4149, 10.1021/am3008888 · DOI
  65. Meenach, 2012, Synthesis, optimization, and characterization of camptothecin-loaded acetalated dextran porous microparticles for pulmonary delivery, Mol. Pharm., 9, 290, 10.1021/mp2003785 · DOI
  66. Wang, 2017, Development and physicochemical characterization of acetalated dextran aerosol particle systems for deep lung delivery, Int. J. Pharm., 525, 264, 10.1016/j.ijpharm.2017.04.052 · DOI
  67. Chen, 2016, Degradation of acetalated dextran can be broadly tuned based on cyclic acetal coverage and molecular weight, Int. J. Pharm., 512, 147, 10.1016/j.ijpharm.2016.08.031 · DOI
  68. Borteh, 2013, Electrospun acetalated dextran scaffolds for temporal release of therapeutics, Langmuir, 29, 7957, 10.1021/la400541e · DOI
  69. Curcio, 2020, Self-assembling Dextran prodrug for redox- and pH-responsive co-delivery of therapeutics in cancer cells, Colloids Surf. B Biointerfaces, 185, 110537, 10.1016/j.colsurfb.2019.110537 · DOI
  70. Jalalvandi, 2018, Preparation of a pH sensitive hydrogel based on dextran and polyhydrazide for release of 5-flurouracil, an anticancer drug, J. Drug Deliv. Sci. Technol., 44, 146, 10.1016/j.jddst.2017.12.011 · DOI
  71. Wu, 2022, Dextran and peptide-based pH-sensitive hydrogel boosts healing process in multidrug-resistant bacteria-infected wounds, Carbohydr. Polym., 278, 118994, 10.1016/j.carbpol.2021.118994 · DOI
  72. Thambi, 2014, Bioreducible Carboxymethyl Dextran Nanoparticles for Tumor-Targeted Drug Delivery, Adv. Healthc. Mater., 3, 1829, 10.1002/adhm.201300691 · DOI
  73. Filip, 2015, Biophysical properties of carboxymethyl derivatives of mannan and dextran, Carbohydr. Polym., 134, 6, 10.1016/j.carbpol.2015.07.008 · DOI
  74. Um, 2021, Carboxymethyl dextran-based nanocomposites for enhanced chemo-sonodynamic therapy of cancer, Carbohydr. Polym., 273, 118488, 10.1016/j.carbpol.2021.118488 · DOI
  75. Liu, 2011, Preparation, characterization and MRI application of carboxymethyl dextran coated magnetic nanoparticles, Appl. Surf. Sci., 257, 6711, 10.1016/j.apsusc.2011.02.110 · DOI
  76. Das, 2021, One-pot synthesis of carboxymethyl-dextran coated iron oxide nanoparticles (CION) for preclinical fMRI and MRA applications, Neuroimage, 238, 118213, 10.1016/j.neuroimage.2021.118213 · DOI
  77. Li, 2011, Carboxymethylated dextran-coated magnetic iron oxide nanoparticles for regenerable bioseparation, J. Nanosci. Nanotechnol., 11, 10187, 10.1166/jnn.2011.5002 · DOI
  78. Gaowa, 2015, Enhancement of anti-tumor activity of hybrid peptide in conjugation with carboxymethyl dextran via disulfide linkers, Eur. J. Pharm. Biopharm., 92, 228, 10.1016/j.ejpb.2015.03.015 · DOI
  79. Knez, 2020, Structural and magnetic characteristics of carboxymethyl dextran coated magnetic nanoparticles: From characterization to immobilization application, React. Funct. Polym., 148, 104481, 10.1016/j.reactfunctpolym.2020.104481 · DOI
  80. Cha, 2017, Increased susceptibility of IDH2-deficient mice to dextran sodium sulfate-induced colitis, Redox Biol., 13, 32, 10.1016/j.redox.2017.05.009 · DOI
  81. Chen, 2007, Designing chitosan-dextran sulfate nanoparticles using charge ratios, Aaps PharmSciTech, 8, 131, 10.1208/pt0804098 · DOI
  82. Zhao, 2022, Rapid and sensitive detection of dextran sulfate sodium based on supramolecular self-assembly of a perylene diimide derivative in aqueous solution, Spectrochim. Acta Part A Mol. Biomol. Spectrosc., 270, 120760, 10.1016/j.saa.2021.120760 · DOI
  83. Arafa, 2009, Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model, Food Chem. Toxicol., 47, 1311, 10.1016/j.fct.2009.03.003 · DOI
  84. Balaha, 2016, Garlic oil inhibits dextran sodium sulfate-induced ulcerative colitis in rats, Life Sci., 146, 40, 10.1016/j.lfs.2016.01.012 · DOI
  85. Arigesavan, 2015, Carvacrol exhibits anti-oxidant and anti-inflammatory effects against 1,2-dimethyl hydrazine plus dextran sodium sulfate induced inflammation associated carcinogenicity in the colon of Fischer 344 rats, Biochem. Biophys. Res. Commun., 461, 314, 10.1016/j.bbrc.2015.04.030 · DOI
  86. Yao, 2010, Anti-oxidant Effects of Resveratrol on Mice with DSS-induced Ulcerative Colitis, Arch. Med. Res., 41, 288, 10.1016/j.arcmed.2010.05.002 · DOI
  87. Hong, 2017, Anti-inflammatory effect of glucose-lysine Maillard reaction products on intestinal inflammation model in vivo, Int. Immunopharmacol., 52, 324, 10.1016/j.intimp.2017.09.009 · DOI
  88. Liu, 2017, Anti-inflammatory and Anti-oxidant Effects of Licorice Flavonoids on Ulcerative Colitis in Mouse Model, Chin. Herb. Med., 9, 358, 10.1016/S1674-6384(17)60116-3 · DOI
  89. Seo, 2017, Anti-colitis effect of Lactobacillus sakei K040706 via suppression of inflammatory responses in the dextran sulfate sodium-induced colitis mice model, J. Funct. Foods, 29, 256, 10.1016/j.jff.2016.12.045 · DOI
  90. Asari, 2022, Polygonum tinctorium leaves suppress sodium dextran sulfate-induced colitis through interleukin-10-related pathway, Biochem. Biophys. Rep., 30, 101272
  91. Wieber, 2011, Characterisation and stability studies of a hydrophilic decapeptide in different adjuvant drug delivery systems: A comparative study of PLGA nanoparticles versus chitosan-dextran sulphate microparticles versus DOTAP-liposomes, Int. J. Pharm., 421, 151, 10.1016/j.ijpharm.2011.09.011 · DOI
  92. Wang, 2020, Polyelectrolyte three layer nanoparticles of chitosan/dextran sulfate/chitosan for dual drug delivery, Colloids Surf. B Biointerfaces, 190, 110925, 10.1016/j.colsurfb.2020.110925 · DOI
  93. Lalani, J., and Misra, A. (2011). Challenges in Delivery of Therapeutic Genomics and Proteomics, Elsevier.
  94. Siewert, 2019, Investigation of charge ratio variation in mRNA—DEAE-dextran polyplex delivery systems, Biomaterials, 192, 612, 10.1016/j.biomaterials.2018.10.020 · DOI
  95. Ju, 2021, Investigation of dextran adsorption on polycrystalline cerium oxide surfaces, Appl. Surf. Sci., 544, 148890, 10.1016/j.apsusc.2020.148890 · DOI
  96. Piazza, 2017, Magnetic nanohydrogel obtained by miniemulsion polymerization of poly(acrylic acid) grafted onto derivatized dextran, Carbohydr. Polym., 178, 378, 10.1016/j.carbpol.2017.09.019 · DOI
  97. Curcio, 2017, pH/redox dual-sensitive dextran nanogels for enhanced intracellular drug delivery, Eur. J. Pharm. Biopharm., 117, 324, 10.1016/j.ejpb.2017.05.002 · DOI
  98. He, 2021, Preparation of magnetic microgels based on dextran for stimuli-responsive release of doxorubicin, J. Magn. Magn. Mater., 517, 167394, 10.1016/j.jmmm.2020.167394 · DOI
  99. Yu, 2020, Facile preparation of pH/reduction dual-stimuli responsive dextran nanogel as environment-sensitive carrier of doxorubicin, Polymer, 200, 122585, 10.1016/j.polymer.2020.122585 · DOI
  100. Almeida, 2013, Synthesis of a dextran based thermo-sensitive drug delivery system by gamma irradiation, Int. J. Biol. Macromol., 61, 150, 10.1016/j.ijbiomac.2013.07.002 · DOI
  101. Pacelli, 2021, Dextran-polyethylene glycol cryogels as spongy scaffolds for drug delivery, Int. J. Biol. Macromol., 166, 1292, 10.1016/j.ijbiomac.2020.10.273 · DOI
  102. Prusty, 2018, Nano silver decorated polyacrylamide/dextran nanohydrogels hybrid composites for drug delivery applications, Mater. Sci. Eng. C, 85, 130, 10.1016/j.msec.2017.11.028 · DOI
  103. He, 2022, Fabrication of soy protein isolate-succinic anhydride-dextran nanogels: Properties, performance, and controlled release of curcumin, LWT, 160, 113259, 10.1016/j.lwt.2022.113259 · DOI
  104. Zhang, 2022, Preparation and characterization of soybean protein isolate-dextran conjugate-based nanogels, Food Chem., 384, 132556, 10.1016/j.foodchem.2022.132556 · DOI
  105. Matsushige, 2022, RGD-modified dextran hydrogel promotes follicle growth in three-dimensional ovarian tissue culture in mice, Theriogenology, 183, 120, 10.1016/j.theriogenology.2022.02.009 · DOI
  106. Zhao, 2022, Dextran, as a biological macromolecule for the development of bioactive wound dressing materials: A review of recent progress and future perspectives, Int. J. Biol. Macromol., 207, 666, 10.1016/j.ijbiomac.2022.02.114 · DOI
  107. Su, 2021, Dextran hydrogels via disulfide-containing Schiff base formation: Synthesis, stimuli-sensitive degradation and release behaviors, Carbohydr. Polym., 265, 118085, 10.1016/j.carbpol.2021.118085 · DOI
  108. Dhaneshwar, 2006, Dextran: A promising macromolecular drug carrier, Indian J. Pharm. Sci., 68, 705, 10.4103/0250-474X.31000 · DOI
  109. Garg, 2014, In-vitro and in-vivo assessment of dextran-appended cellulose acetate phthalate nanoparticles for transdermal delivery of 5-fluorouracil, Drug Deliv., 23, 1525
  110. Tiyaboonchai, 2001, Formulation and characterization of amphotericin B–polyethylenimine–dextran sulfate nanoparticles, J. Pharm. Sci., 90, 902, 10.1002/jps.1042 · DOI
  111. Abid, 2020, Colon specific enzyme responsive oligoester crosslinked dextran nanoparticles for controlled release of 5-fluorouracil, Int. J. Pharm., 586, 119605, 10.1016/j.ijpharm.2020.119605 · DOI
  112. Wu, 2016, Zwitterionic pH/redox nanoparticles based on dextran as drug carriers for enhancing tumor intercellular uptake of doxorubicin, Mater. Sci. Eng. C, 61, 278, 10.1016/j.msec.2015.12.025 · DOI
  113. Dai, 2014, Folic acid-conjugated glucose and dextran coated iron oxide nanoparticles as MRI contrast agents for diagnosis and treatment response of rheumatoid arthritis, J. Mater. Chem. B, 2, 2240, 10.1039/C3TB21732A · DOI
  114. Kaewprapan, 2012, Enzymatically degradable nanoparticles of dextran esters as potential drug delivery systems, Carbohydr. Polym., 88, 875, 10.1016/j.carbpol.2012.01.030 · DOI
  115. Ferrari, 2021, Dextran/poly-L-arginine multi-layered CaCO3-based nanosystem for vascular drug delivery, Int. J. Biol. Macromol., 177, 548, 10.1016/j.ijbiomac.2021.02.058 · DOI
  116. Lungoci, 2018, Biosynthesized dextran coated magnetic nanoparticles with antifungal activity, Rev. Roum. Chim., 63, 497
  117. Anghelache, M., Turtoi, M., Petrovici, A.R., Fifere, A., Pinteala, M., and Calin, M. (2021). Development of Dextran-Coated Magnetic Nanoparticles Loaded with Protocatechuic Acid for Vascular Inflammation Therapy. Pharmaceutics, 13. · DOI
  118. Wasiak, I., Kulikowska, A., Janczewska, M., Michalak, M., Cymerman, I.A., Nagalski, A., Kallinger, P., Szymanski, W.W., and Ciach, T. (2016). Dextran nanoparticle synthesis and properties. PLoS ONE, 11. · DOI
  119. Zhang, 2017, Ingenious pH-sensitive dextran/mesoporous silica nanoparticles based drug delivery systems for controlled intracellular drug release, Int. J. Biol. Macromol., 98, 691, 10.1016/j.ijbiomac.2017.01.136 · DOI
  120. Zhu, 2015, Efficient nuclear drug translocation and improved drug efficacy mediated by acidity-responsive boronate-linked dextran/cholesterol nanoassembly, Biomaterials, 52, 281, 10.1016/j.biomaterials.2015.02.048 · DOI
  121. Wu, 2013, Development of dextran nanoparticles for stabilizing delicate proteins, Nanoscale Res. Lett., 8, 197, 10.1186/1556-276X-8-197 · DOI
  122. Kesharwani, 2018, Nanotechnology based approaches for anti-diabetic drugs delivery, Diabetes Res. Clin. Pract., 136, 52, 10.1016/j.diabres.2017.11.018 · DOI
  123. Soliman, 2018, Light-sensitive dextran-covered PNBA nanoparticles as triggered drug delivery systems: Formulation, characteristics and cytotoxicity, J. Colloid Interface Sci., 514, 289, 10.1016/j.jcis.2017.12.036 · DOI
  124. Medhat, 2017, Effect of Au-dextran NPs as anti-tumor agent against EAC and solid tumor in mice by biochemical evaluations and histopathological investigations, Biomed. Pharmacother., 91, 1006, 10.1016/j.biopha.2017.05.043 · DOI
  125. Sajid, 2021, Synthesis, characterization, and cytotoxicity evaluation of dextran-myristoyl-ECGKRK peptide conjugate, Int. J. Biol. Macromol., 191, 1204, 10.1016/j.ijbiomac.2021.09.160 · DOI
  126. Kashyap, 2018, Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites, Int. J. Biol. Macromol., 114, 161, 10.1016/j.ijbiomac.2018.03.102 · DOI
  127. Sampath, 2020, The remarkable role of emulsifier and chitosan, dextran and PEG as capping agents in the enhanced delivery of curcumin by nanoparticles in breast cancer cells, Int. J. Biol. Macromol., 162, 748, 10.1016/j.ijbiomac.2020.06.188 · DOI
  128. Bai, 2018, Reduction stimuli-responsive unimolecular polymeric prodrug based on amphiphilic dextran-framework for antitumor drug delivery, Carbohydr. Polym., 182, 235, 10.1016/j.carbpol.2017.11.028 · DOI
  129. Chen, Z., Krishnamachary, B., and Bhujwalla, Z.M. (2016). Degradable dextran nanopolymer as a carrier for choline kinase (Chok) siRNA cancer therapy. Nanomaterials, 6. · DOI
  130. Jiang, 2021, Preparation of dextran-casein phosphopeptide conjugates, evaluation of its calcium binding capacity and digestion in vitro, Food Chem., 352, 129332, 10.1016/j.foodchem.2021.129332 · DOI
  131. Parhizkar, 2022, Synthesis, cytotoxicity assay, pharmacokinetics, biodistribution and modeling study of cabazitaxel-dextran nanoconjugates: Targeted vs non targeted delivery, Colloids Surf. B Biointerfaces, 209, 112187, 10.1016/j.colsurfb.2021.112187 · DOI
  132. Kim, 2017, Conjugation of metronidazole with dextran: A potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes, Drug Des. Devel. Ther., 11, 419, 10.2147/DDDT.S129922 · DOI
  133. Zhang, 2020, The design and synthesis of dextran-doxorubicin prodrug-based pH-sensitive drug delivery system for improving chemotherapy efficacy, Asian J. Pharm. Sci., 15, 605, 10.1016/j.ajps.2019.10.001 · DOI
  134. Jin, 2017, Amphipathic dextran-doxorubicin prodrug micelles for solid tumor therapy, Colloids Surf. B Biointerfaces, 158, 47, 10.1016/j.colsurfb.2017.06.023 · DOI
  135. Zhang, 2022, Ultra-stable dextran conjugated prodrug micelles for oxidative stress and glycometabolic abnormality combination treatment of Alzheimer’s disease, Int. J. Biol. Macromol., 203, 430, 10.1016/j.ijbiomac.2022.01.154 · DOI

Cited by

Sorted by citations

See all 130

Metadata

Authors
Petrovici, A. R., Pinteala, M., & Simionescu, N.
Venue
Molecules
Publisher
MDPI AG
Published
2023-01-21
Volume
28
Issue
3
Pages
1086
ISSN
1420-3049
DOI
10.3390/molecules28031086
PMC
PMC9920038
Cited by
130
References
2
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)
Funders
Ministry of Research, Innovation and Digitization, CCCDI—UEFISCDI (PN-III-P2-2.1-PED-2021-2193)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dextran Formulations as Effective Delivery Systems of Therapeutic Agents. https://app.cochat.ai/papers/10.3390/molecules28031086
The paper
Petrovici, A. R., Pinteala, M., & Simionescu, N. (2023). Dextran Formulations as Effective Delivery Systems of Therapeutic Agents. Molecules. https://doi.org/10.3390/molecules28031086